# Sildenafil Efficacy Study on Time Walk From Peripheral Arterial Desease Patients (Stade II) With Arterial Claudication

> **NCT02832570** · PHASE3 · COMPLETED · sponsor: **University Hospital, Angers** · enrollment: 14 (actual)

## Conditions studied

- Peripheral Arterial Occlusive Disease

## Interventions

- **DRUG:** Sildenafil 100mg single oral dose
- **DRUG:** Placebo, Oral intake single dose

## Key facts

- **NCT ID:** NCT02832570
- **Lead sponsor:** University Hospital, Angers
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-07
- **Primary completion:** 2017-10
- **Final completion:** 2017-10
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2022-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02832570

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02832570, "Sildenafil Efficacy Study on Time Walk From Peripheral Arterial Desease Patients (Stade II) With Arterial Claudication". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02832570. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*